Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mixing Muscle Relaxants and Anesthetics Raises Respiratory Risk

By HospiMedica International staff writers
Posted on 03 Oct 2018
A new study concludes that administering neuromuscular blocking drugs during general anesthesia (GA) is associated with an increased risk of postoperative pulmonary complications.

Researchers at Munich Technical University (TUM; Germany), Karolinska Institutet (KI; Solna, Sweden), the University of Liverpool (United Kingdom), and other institutions conducted a multicenter observational study to assess if neuromuscular blocking agent use is associated with postoperative pulmonary complications. More...
To do so, they collected data from 22,803 patients who received anesthesia for any in-hospital procedure--except cardiac surgery--conducted in 211 hospitals in 28 European countries over the course of a year.

Patient characteristics, surgical and anesthetic details, and chart review at discharge were prospectively collected over two weeks. Each patient also had a postoperative physical examination within three days of surgery for adverse pulmonary events. Overall, about three quarters of all patients (17,150 people) were treated with neuromuscular blocking agents. The most common respiratory complications were a transient reduced lung capacity for oxygen absorption (5.2%), and infections of the lung and respiratory tract (2.5%).

The results showed that patients receiving neuromuscular blocking agents while under GA had a significantly higher (4.4%) risk of developing any type of respiratory complication. The study also showed that neither neuromuscular monitoring, nor the administration of reversal agents reduced the risk. The researchers are now planning to implement more targeted studies in order to identify the underlying mechanisms behind their findings. The study was published on September 14, 2018, in Lancet Respiratory Medicine.

“Neuromuscular blocking agents have made surgery considerably safer and more effective since their introduction. These drugs are particularly needed when operating on a patient's chest or abdomen. They are also used to protect the vocal cords from injury when a tube is placed in the airway to allow artificial ventilation,” said senior author Professor Manfred Blobner, MD, of TUM. “Patients undergoing minor surgical procedures that do not necessarily require neuromuscular blocking drugs might benefit from avoiding them. Using devices like laryngeal masks for anesthesia instead of tracheal tubes that go past the vocal cords could prove helpful as well.”

Related Links:
Munich Technical University
Karolinska Institutet
University of Liverpool


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.